Clinical Trial Update: Post-Marketing Study Using PROLIEVE® for the Treatment of Benign Prostatic Hyperplasia (BPH) [Phase 4]

View source ↗

Summary

Phase 4 post-marketing trial update for PROLIEVE in the treatment of Benign Prostatic Hyperplasia. Current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• PROLIEVE

Snippet

Sponsor: Medifocus, Inc. | Conditions: Benign Prostate Hyperplasia | Phase 4 | Status: UNKNOWN